Evista (Raloxifene) can both prevent breast cancer and prevent osteoporosis! Evista has been approved for both indications. Not often can a woman treat two dreaded conditions with a single pill.
Evista is very similar to human estrogen. Evista is an “Estrogen-Agonist-Antagonist”. That means Evista acts like natural human estrogen when it prevents osteoporosis. But Evista also blocks human estrogen when it prevents breast cancer.
Evista convinces the OsteoCytes that estrogen is on board. The OsteoCytes release Osteoprotegrin (OPG), which is the natural substance that keeps the OsteoClasts (the cells that gobble up your bone) from going wild. Your bone is preserved, just like it was before menopause. This action is just like Hormone Replacement Therapy (HRT).
The most common side effect of Evista is menopausal-like symptoms. Fortunately, these usually fade within 1 to 2 months. Rare side effects include a slight increase in blood clots in persons with a personal history of blood clots or a strong family history. We also suspect a slight increase in heart problems over the age of 70, as in HRT, but not enough women have taken Evista beyond the age of 70 to find out if this is true.
Evista is a daily pill with no heartburn or GERD issues. It preserves bone by stimulating the natural process of a premenopausal state. Evista prevents breast cancer. Evista is a great choice for women looking for that combination.
Take control of your future.
Jay Ginther, MD